Biotech funding is on the rise and Biotech IPOs are healthy

Venture-backed healthcare deals rise to $2.7B in Q2 (MedCityNews)
About $13.88 billion in venture capital backed 974 deals in the second quarter, the highest level since the first quarter of 2001, according to a new report by CB Insights. Healthcare accounted for a significant part of that. About $2.7 billion was invested across 161 deals in the sector. CB Insights’ Venture Capital Activity report called attention to some interesting VC trends in healthcare from IPO activity to a growing shift away from early-stage deals.
Healthcare IPOs accounted for half of venture-backed IPO activity for t...